本页面由Tiger Trade Technology Pte. Ltd.提供服务

Vor Biopharma Inc.

13.57
+0.63004.87%
盘前14.310.7400+5.45%08:03 EDT
成交量:102.22万
成交额:1,389.54万
市值:5.63亿
市盈率:-0.04
高:14.24
开:12.84
低:12.65
收:12.94
52周最高:65.80
52周最低:2.62
股本:4,151.98万
流通股本:1,897.14万
量比:0.60
换手率:5.39%
股息:- -
股息率:- -
每股收益(TTM):-386.8600
每股收益(LYR):-34.0333
净资产收益率:-125.43%
总资产收益率:-144.27%
市净率:-0.25
市盈率(LYR):-0.40

数据加载中...

2025/09/02

重要事件披露

Form 8-K - Current report
2025/08/27

重要事件披露

Form 8-K - Current report
2025/08/27

重要事件披露

Form 8-K - Current report
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/22

重要事件披露

Form 8-K - Current report
2025/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 | VOR BIOPHARMA INC.高管 Robert Ang 拟减持214135股,总价约52万美元
2025/07/10

重要事件披露

Form 8-K - Current report
2025/07/10

关联方拟减持公告

Form 144 | VOR BIOPHARMA INC. 高管 Robert Ang 拟减持596885股,总价约138.8万美元
2025/07/03

关联方拟减持公告

Form 144 | VOR BIOPHARMA高管 Robert Ang 拟减持44936股,总价约8.04万美元
2025/07/01

关联方拟减持公告

Form 144 | VOR BIOPHARMA高管Robert Ang拟减持40468股,总价约69613美元
2025/06/30

关联方拟减持公告

Form 144 | VOR BIOPHARMA INC. 高管 Robert Ang 拟减持40627股,总价约70289美元
2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/21

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/25

重要事件披露

Form 8-K - Current report